CSIR, Laxai Life Sciences Receives Regulatory Approval for Colchicine Clinical Trials on Covid-19 Patients
Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt Ltd Hyderabad has been given the regulatory approval […]
Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt Ltd Hyderabad has been given the regulatory approval […]
The Covid-19 pandemic has played a havoc role for humans across the globe. The first line of defence against the […]
The Chimeric Antigen Receptor T-cell (CAR-T) therapy has emerged as a breakthrough in cancer treatment. Clinical trials conducted globally have […]
Indian Institute of Chemical Technology, (IICT), a constituent laboratory of CSIR and Hyderabad-based Lee Pharma, an integrated pharmaceutical company, has […]
CSIR in collaboration with Laxai Life Sciences Pvt Ltd, has initiated the phase-II clinical trial with anti-helminitic drug Niclosamide for […]
Cancer kills 8.51 lakh people in India every year, according to International Agency for Research on Cancer, 2020, Globocan). As […]
The Union Ministry of Health and Family Welfare (MoHFW) has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to reserve 30 […]
A 500-bed Covid Care Hospital set up by Defence Research and Development Organisation (DRDO) in Haldwani was virtually inaugurated by […]
With mortality rates of Covid-19 being higher among patients with co-morbidities which are directly related to tobacco, Rajiv Gandhi Cancer […]
The World Health Assembly, the main governing body of the World Health Organization, has adopted a new resolution that aims […]
As researchers, industrialists and entrepreneurs synergized their capabilities and efforts to fight this massive battle at all fronts, several science-based […]
The Indian Council of Medical Research or ICMR will initiate a survey next week for examining the effectiveness of AstraZeneca’s […]
Since the outbreak of the Covid-19 pandemic, India has been making multiple strides in augmenting its testing infrastructure and capacity. […]